Dictionary.com
Thesaurus.com

oncology

American  
[ong-kol-uh-jee] / ɒŋˈkɒl ə dʒi /

noun

  1. the branch of medical science dealing with tumors, including the origin, development, diagnosis, and treatment of malignant neoplasms.

  2. the study of cancer.


oncology British  
/ ˌɒŋkəˈlɒdʒɪkəl, ɒŋˈkɒlədʒɪ /

noun

  1. the branch of medicine concerned with the study, classification, and treatment of tumours

"Collins English Dictionary — Complete & Unabridged" 2012 Digital Edition © William Collins Sons & Co. Ltd. 1979, 1986 © HarperCollins Publishers 1998, 2000, 2003, 2005, 2006, 2007, 2009, 2012

oncology Scientific  
/ ŏn-kŏlə-jē /
  1. The branch of medicine that deals with the diagnosis and treatment of cancer.


oncology Cultural  
  1. The branch of medicine devoted to the study, treatment, and cure of cancer.


Other Word Forms

  • oncologic adjective
  • oncological adjective
  • oncologist noun

Etymology

Origin of oncology

First recorded in 1855–60; onco- + -logy

Example Sentences

Examples are provided to illustrate real-world usage of words in context. Any opinions expressed do not reflect the views of Dictionary.com.

"This progress paves the way for applications in oncology, neurology and immunology. It changes how we think about nanoparticles - not only as delivery tools but also as active therapeutic agents," said Professor Shi.

From Science Daily

The surge has been driven in part by “investor positioning ahead of multiple oncology readouts expected this year,” said Evercore’s Kasimov.

From Barron's

The surge has been driven in part by “investor positioning ahead of multiple oncology readouts expected this year,” said Evercore’s Kasimov.

From Barron's

Within its “innovative medicine” portfolio, J&J is now focused on oncology, immunology and neuroscience drugs, while its medical-technology business will hold on to its cardiovascular, surgical and vision care device businesses.

From MarketWatch

“We continue to invest in our platform in oncology because of encouraging outcomes like these, which illustrate mRNA’s potential in cancer care,” said Kyle Holen, a senior vice president at Moderna.

From The Wall Street Journal